Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.

PLoS One · 2010 · PMC2873993 · PMID 20505772

Europe PMC DOI

hedged sentence

0.4200

closest p · 8.4× alpha

0.4200

boldest claim

The sentences

showed a trendp = 0.42not close (p > 0.1)

However, at 15 U/kg/wk doses, the Vela-injected mice showed a trend toward greater (∼66%) reductions of GC levels compared to ∼55% in Imig injected mice (p = 0.42).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.